Please login to the form below

Not currently logged in
Email:
Password:

BenevolentAI raises $115m to fund drug development

BenevolentAI

Its technology could cut the early stage drug discovery process by four years, says the company

Shire rebuffs Takeda bids, as Allergan bows out

ShireAllergan doesn’t intend to make a formal offer following a dip in its share prices

Spirit Health Group offers new market access consultancy service

GlobeSpirit Access will support the pharmaceutical and device industries

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

Merck KGaAWill also access Merck’s big-selling Neurobion and the Nasivin nasal decongestant range

Publicis LifeBrands Team win UK young Cannes Lions competition

Cannes LIonsTom Wordley and Jon Webb will represent the UK at the competition

Rigel and Ultragenyx claim approvals for rare drugs

Tavalisse and Crysvita are set to treat patients with chronic ITP and XLH, respectively

Amgen and Novartis migraine drug hits the mark again

Amgen flagAimovig will become the first CGRP receptor-targeting drug if it reaches market

Good Relations win Nuffield Health account

good relationsThe agency will combine Nuffield Health’s gym and hospital offerings

Sanofi sells European generics to Advent for $2.4bn

Sanofi receptionThe deal will create a new, independent European generics company

The shifting healthcare landscape

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics